Wed Jun 06 2018
suPARnostic® Approval in India
The suPARnostic® product has been approved by the Central Drugs Standard Control Organisation, New Delhi, and given permission to import, for which Form 10 license was issued in May 2017.
Congratulations to our distributor Super Biotech Pvt Ltd, who already has trials of the suPARnostic® product running at several hospitals in India.
Super Biotech Pvt Ltd has added a new phone number +91 11 45073677 specially for suPAR inquiries in India.
Contact information to Super Biotech – please see here